Valerio Therapeutics (ALVIO) Financial Statements

0 Followers

Valerio Therapeutics Financial Overview

Valerio Therapeutics's market cap is currently €84.76M. The company's EPS TTM is €; its P/E ratio is -1.14; Valerio Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Jun 25	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	€ 2.57M	€ 1.79M	€ 1.80M	€ 1.44M	€ 4.06M
Gross Profit	€ 1.73M	€ 1.28M	€ 1.27M	€ 929.00K	€ 3.69M
Operating Income	€ -550.00K	€ -16.49M	€ -20.29M	€ -17.11M	€ -7.33M
EBITDA	€ 542.00K	€ -12.06M	€ -18.44M	€ -17.04M	€ -5.86M
Net Income	€ -4.90M	€ -23.93M	€ -20.34M	€ -19.56M	€ -5.94M
Balance Sheet
Cash & Short-Term Investments	€ 1.05M	€ 1.18M	€ 6.82M	€ 14.59M	€ 17.89M
Total Assets	€ 15.23M	€ 17.93M	€ 35.27M	€ 43.09M	€ 53.06M
Total Debt	€ 7.61M	€ 13.44M	€ 9.00M	€ 10.09M	€ 9.94M
Net Debt	€ 6.55M	€ 12.26M	€ 2.18M	€ -4.50M	€ -3.12M
Total Liabilities	€ 13.16M	€ 26.19M	€ 20.47M	€ 20.82M	€ 20.12M
Stockholders' Equity	€ 2.08M	€ -8.93M	€ 14.80M	€ 22.27M	€ 32.94M
Cash Flow
Free Cash Flow	€ 521.00K	€ -12.78M	€ -18.78M	€ -9.93M	€ -8.71M
Operating Cash Flow	€ 1.84M	€ -12.46M	€ -18.60M	€ -9.44M	€ -8.57M
Investing Cash Flow	€ -1.16M	€ -1.39M	€ -177.00K	€ -409.00K	€ -66.00K
Financing Cash Flow	€ -774.00K	€ 4.21M	€ 10.76M	€ 6.46M	€ 11.98M

Currency in EUR

Valerio Therapeutics Earnings and Revenue History

Income Statement >

Valerio Therapeutics Debt to Assets

Balance Sheet >

Valerio Therapeutics Cash Flow

Cash Flow >

Valerio Therapeutics Forecast EPS vs Actual EPS

Earnings >